TGFB1 and COVID-19: Since SARS-CoV-2 infection forms a favorable microenvironment for TGFβ activation upon its release from hyperactive platelets [60], platelet-derived TGFβ could significantly contribute to the pathogenesis of COVID-19 and lung failure.